First Time Loading...

Ekso Bionics Holdings Inc
NASDAQ:EKSO

Watchlist Manager
Ekso Bionics Holdings Inc Logo
Ekso Bionics Holdings Inc
NASDAQ:EKSO
Watchlist
Price: 1.2 USD -4.76% Market Closed
Updated: May 29, 2024

Ekso Bionics Holdings Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ekso Bionics Holdings Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Ekso Bionics Holdings Inc
NASDAQ:EKSO
Cash & Cash Equivalents
$8.8m
CAGR 3-Years
-44%
CAGR 5-Years
-1%
CAGR 10-Years
-5%
Becton Dickinson and Co
NYSE:BDX
Cash & Cash Equivalents
$2.3B
CAGR 3-Years
-14%
CAGR 5-Years
28%
CAGR 10-Years
3%
Boston Scientific Corp
NYSE:BSX
Cash & Cash Equivalents
$2.3B
CAGR 3-Years
5%
CAGR 5-Years
76%
CAGR 10-Years
28%
Stryker Corp
NYSE:SYK
Cash & Cash Equivalents
$2.3B
CAGR 3-Years
1%
CAGR 5-Years
7%
CAGR 10-Years
5%
Abbott Laboratories
NYSE:ABT
Cash & Cash Equivalents
$6.3B
CAGR 3-Years
-8%
CAGR 5-Years
16%
CAGR 10-Years
12%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash & Cash Equivalents
$2.8B
CAGR 3-Years
27%
CAGR 5-Years
27%
CAGR 10-Years
13%

See Also

What is Ekso Bionics Holdings Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
8.8m USD

Based on the financial report for Mar 31, 2024, Ekso Bionics Holdings Inc's Cash & Cash Equivalents amounts to 8.8m USD.

What is Ekso Bionics Holdings Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-5%

Over the last year, the Cash & Cash Equivalents growth was -46%. The average annual Cash & Cash Equivalents growth rates for Ekso Bionics Holdings Inc have been -44% over the past three years , -1% over the past five years , and -5% over the past ten years .